Royal Philips has entered an agreement with the Singapore Institute of Advanced Medicine Holdings (SAM) to build a new oncology centre in the country.

To be built in collaboration with Varian Medical Systems and IBA Worldwide, and based at the country’s biomedical research hub Biopolis, the new Advanced Medicine Oncology Centre will offer imaging, treatment delivery and clinical informatics technologies.

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

SAM is set to invest approximately S$100m ($72m) for the development of the research, training and treatment centre that is scheduled to open in stages from next year.

In addition to oncology solutions for healthcare professionals and researchers, the centre is expected to provide a professional training platform.

The centre will also act as a site for research, clinical trials and cancer therapies development, delivering treatment protocols for personalised patient care, better outcomes and improved quality of life.

Singapore Institute of Advanced Medicine Holdings founder and chairman Dr Djeng Shih Kien said: “The new Advanced Medicine Oncology Centre aligns with the founding goal of the Singapore Institute of Advanced Medicine Holdings to provide earlier detection and first-time-right diagnosis of cancer as well as safer, more cost-effective treatment by advancing care enabled through research, technology and education.”

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData
"The centre will also act as a site for research, clinical trials and cancer therapies development, delivering treatment protocols for personalised patient care, better outcomes and improved quality of life."

Philips’ diagnostic imaging systems and clinical informatics such as Ingenia MR, IQon spectral CT systems and Vereos PET/CT scanners will be available at the new centre. Varian’s ProBeam Compact system and IBA’s Cyclone Kiube technology will also be accessible.

Philips ASEAN Pacific Health Systems general manager Diederik Zeven said: “Philips is enabling the advancement of medical research through our deep heritage in healthcare innovation and collaboration with medical partners.

“The new Advanced Medicine Oncology Centre is well-positioned to spearhead cancer research and treatment in Singapore and the region."

The oncology centre will also use Philips IntelliSpace Portal 9.0 to enable advanced visual analysis and quantification of medical images resulting in fast assessment and diagnosis.


Image: Philips Vereos PET/CT scanner is the world’s first and only fully digital PET/CT system. Photo: courtesy of Koninklijke Philips NV.

Medical Device Network Excellence Awards - Nominations Closed

Nominations are now closed for the Medical Device Network Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact

Excellence in Action
SC MEDICA’s minimally invasive, radiation free spinal facet fixation system, FFX® is transforming spinal pain management and improving outcomes for surgeons and patients alike. Learn how SC MEDICA’s award-winning technology is redefining standards in facet joint pain treatment.

Discover the Impact